Nau IB Capital is a Korea-based company engaged in the new technology project financing business. The Company operates investment associations and private equity funds (PEF), mainly engaged in the investment and recovery of new technology business providers, venture companies and others.

Employees

Sector

Investment Management & Fund Operators

Calendar

18/12 Significant Split/Dividend

More about the company

Quotes

Date	Price	Change	Volume
23/26/23	₩1,275.00	+2.99%	3,56,121
22/26/22	₩1,238.00	+2.74%	2,88,830
21/26/21	₩1,205.00	-3.37%	2,78,997
18/26/18	₩1,247.00	-0.95%	2,74,109
17/26/17	₩1,259.00	+1.94%	3,23,737

End-of-day quote Korea S.E.

More quotes

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

End-of-day quote Korea S.E. 23/09/2026			5-day change	1st Jan Change
1,275.00 ^KRW	+2.99%		+2.25%	-17.74%

30/04	Daedong Korea Ginseng Co., Ltd. announced that it has received KRW 3 billion in funding from Nau IB Capital, Investment Arm	CI
29/04	Namu Tech Co.,Ltd. announced that it has received KRW 6 billion in funding from Nau IB Capital, Investment Arm	CI

Market Cap	12TCr 8.92Cr 7.82Cr 7.39Cr 6.73Cr 13Cr 854.58Cr 13Cr 88Cr 34Cr 436.59Cr 33Cr 33Cr 1.4TCr	P/E 2024	13.8x	P/E 2025	25.4x
Enterprise Value	11TCr 8.02Cr 7.04Cr 6.65Cr 6.06Cr 11Cr 768.98Cr 11Cr 80Cr 31Cr 392.85Cr 30Cr 29Cr 1.26TCr	EV / Sales 2024	5.61x	EV / Sales 2025	6.53x
Free-Float	34.96%	Yield 2024	1.72%	Yield 2025	-

30/04	Daedong Korea Ginseng Co., Ltd. announced that it has received KRW 3 billion in funding from Nau IB Capital, Investment Arm	CI
29/04	Namu Tech Co.,Ltd. announced that it has received KRW 6 billion in funding from Nau IB Capital, Investment Arm	CI
22/12	Cellumed Co.,Ltd. announced that it expects to receive KRW 16.9999991 billion in funding	CI
06/11	NAU IB Capital announces Annual dividend, payable on April 15, 2026	CI
13/25/13	BIGC Inc. announced that it has received KRW 18 billion in funding from a group of investors	CI
20/23/20	NAU IB Capital Reports Earnings Results for the Full Year Ended December 31, 2022	CI
18/22/18	Tranche Update on NAU IB Capital's Equity Buyback Plan announced on August 18, 2021.	CI
18/22/18	Tranche Update on NAU IB Capital's Equity Buyback Plan announced on August 18, 2021.	CI
18/22/18	Tranche Update on NAU IB Capital's Equity Buyback Plan announced on August 18, 2021.	CI
18/22/18	Tranche Update on NAU IB Capital's Equity Buyback Plan announced on August 18, 2021.	CI
18/22/18	Tranche Update on NAU IB Capital's Equity Buyback Plan announced on August 18, 2021.	CI
18/22/18	NAU IB Capital's Equity Buyback announced on August 18, 2021, has expired with 198,405 shares, representing 2.08% for KRW 1,987.81 million.	CI
20/22/20	Cell Meat announced that it has received $8.1 million in funding from NAU IB Capital, BNK Venture Investment, Strong Ventures, LLC, Ryukyungpsg Asset Management Inc	CI

1 day	+2.99%
1 week	+2.25%
Current month	-13.50%
1 month	-15.00%
3 months	-9.32%
6 months	-29.79%
Current year	-17.74%

NAU IB Capital Share Price

Stocks

A293580

KR7293580007

Investment Management & Fund Operators

Valuation: NAU IB Capital

Chart: NAU IB Capital

Latest news: NAU IB Capital

Quotes and Performance

Price Extremes

Managers and Directors: NAU IB Capital

Latest insider transactions

Venture Capital

Financials

Company Profile

Quotes

1 week	1,183	1,299
1 month	985	1,521
Current year	985	3,350
1 year	985	3,350
3 years	860	3,350
5 years	635	3,350
10 years	258.5	3,350

Manager	Title	Age	Since
Seung-Won Lee CEO	Chief Executive Officer	63	-
Sang Kyu Park CIO	Chief Investment Officer	62	-
Eui-Jong Baek CMP	Compliance Officer	-	-

Director	Title	Age	Since
Seung-Won Lee BRD	Director/Board Member	63	-
Ji-Wan Jeong BRD	Director/Board Member	70	-
Sang Kyu Park BRD	Director/Board Member	62	-

Date	Insider	Type	Main position	Quantity	% Market Cap.
14/05/25	Ji-Wan Jeong	Sell	Director	7,60,000	0.8006%
29/04/25	Hyung-guk Lee	Sell		40,000	0.0421%
29/04/25	Sang Kyu Park	Sell	Chief Investment Officer	30,000	0.0316%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
NAU IB CAPITAL	+2.99%	+2.25%	+6.52%	+4.51%	8.92Cr
BB BIOTECH AG	-0.20%	-2.29%	+41.75%	+22.25%	340.04Cr
HERCULES CAPITAL, INC.	+1.01%	-2.08%	-11.15%	+2.66%	313.25Cr
HBM HEALTHCARE INVESTMENTS AG	+0.88%	-3.36%	+29.94%	+32.18%	183.58Cr
MOLTEN VENTURES PLC	+1.21%	-0.15%	+87.60%	+199.33%	140.29Cr
OCTOPUS APOLLO VCT PLC	0.00%	0.00%	-1.72%	-7.02%	71Cr
MIRAE ASSET VENTURE INVESTMENT CO., LTD.	+2.95%	+0.85%	+116.14%	+267.22%	70Cr
BRITISH SMALLER COMPANIES VCT PLC	0.00%	0.00%	-3.97%	-7.05%	40Cr
OCTOPUS TITAN VCT PLC	+5.71%	+5.71%	-24.49%	-71.54%	40Cr
PEMBROKE VCT PLC	0.00%	0.00%	-0.53%	-13.02%	36Cr
Average	+1.46%	+0.33%	+24.01%	+42.95%	124.38Cr
Weighted average by Cap.	+0.84%	-1.23%	+28.42%	+45.66%

	2024	2025
Net sales	1.41TCr 1.04Cr 91.15L 86.09L 78.45L 1.47Cr 100Cr 1.48Cr 10Cr 3.99Cr 51Cr 3.9Cr 3.82Cr 163.47Cr	2.06TCr 1.52Cr 1.33Cr 1.26Cr 1.15Cr 2.15Cr 145.76Cr 2.17Cr 15Cr 5.84Cr 74Cr 5.71Cr 5.59Cr 239.33Cr
Net income	793.09Cr 58.42L 51.27L 48.42L 44.13L 82.6L 56Cr 83.19L 5.79Cr 2.24Cr 29Cr 2.19Cr 2.15Cr 92Cr	578.33Cr 42.6L 37.39L 35.31L 32.18L 60.23L 41Cr 60.66L 4.23Cr 1.64Cr 21Cr 1.6Cr 1.57Cr 67Cr
Net Debt	-3.09TCr -2.27Cr -2Cr -1.88Cr -1.72Cr -3.21Cr -217.95Cr -3.24Cr -23Cr -8.73Cr -111.35Cr -8.54Cr -8.35Cr -357.85Cr	-1.21TCr -89.32L -78.38L -74.02L -67.46L -1.26Cr -86Cr -1.27Cr -8.86Cr -3.43Cr -44Cr -3.35Cr -3.28Cr -140.56Cr